Yahoo
SES - Delayed Quote SGD

Haw Par Corporation Limited (H02.SI)

12.94 +0.14 (+1.09%)
At close: October 16 at 5:05:00 PM GMT+8
Chart Range Bar
Loading chart for H02.SI
  • Previous Close 12.80
  • Open 12.80
  • Bid 12.89 x --
  • Ask 12.94 x --
  • Day's Range 12.80 - 13.01
  • 52 Week Range 12.58 - 18.27
  • Volume 235,460
  • Avg. Volume 278,399
  • Market Cap (intraday) 2.865B
  • Beta (5Y Monthly) 0.16
  • PE Ratio (TTM) 12.44
  • EPS (TTM) 1.04
  • Earnings Date Aug 14, 2026
  • Forward Dividend & Yield 0.40 (3.09%)
  • Ex-Dividend Date Aug 24, 2026
  • 1y Target Est 14.60

Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases various investment properties. In addition, it provides family and tourist oriented leisure activities primarily in the form of oceanariums. Further, the company is involved in the property development; and owning and letting properties; letting out of office spaces; and management support services. Haw Par Corporation Limited was incorporated in 1969 and is based in Singapore.

www.hawpar.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/16/2026, which may include dividends or other distributions. Benchmark is STI Index (^STI) .

YTD Return

H02.SI
15.39%
STI Index (^STI)
16.56%

1-Year Return

H02.SI
10.90%
STI Index (^STI)
24.32%

3-Year Return

H02.SI
55.63%
STI Index (^STI)
71.17%

5-Year Return

H02.SI
34.75%
STI Index (^STI)
70.63%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY14
Revenue 38.92M
Earnings --
Profit Margin 0.00%

Q4

FY13

Q1

FY14

Q2

FY14

Q3

FY14

0
10M
20M
30M
40M
0.0%

Analyst Insights

View More

Analyst Price Targets

14.60
14.60 Average
12.94 Current
14.60 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 9/23/2026
  • Market Cap

    2.97B

  • Enterprise Value

    -1.45B

  • Trailing P/E

    12.95

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    13.51

  • Price/Book (mrq)

    0.63

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    104.39%

  • Return on Assets (ttm)

    0.91%

  • Return on Equity (ttm)

    5.19%

  • Revenue (ttm)

    219.55M

  • Net Income Avi to Common (ttm)

    229.19M

  • Diluted EPS (ttm)

    1.04

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    669.06M

  • Total Debt/Equity (mrq)

    1.11%

  • Levered Free Cash Flow (ttm)

    36.72M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: